adplus-dvertising
Connect with us

Business

Alberta maps out next stages of vaccine eligibility, reports 65 new variant cases of COVID-19 – Calgary Herald

Published

 on


Once Phase 2A is complete, the province will shift to Phase 2B — likely in April — which would open eligibility for adults with severe underlying conditions

Article content

Alberta has laid out its plan for the next stages of vaccine eligibility, as another 65 variant cases of COVID-19 were detected in the province Monday.

Appointments for Phase 2A of the province’s vaccine rollout opened Monday morning, with 8,000 eligible Albertans signing up for their time slots within the first several hours. Bookings through Alberta Health Services for those eligible will expand to include Albertans born in 1948 or earlier and First Nations, Métis and Inuit individuals born in 1963 or earlier at 10 a.m. on Tuesday.

Phase 2A will continue expanding until bookings are available for Albertans born between 1947 and 1956, and Indigenous individuals born in 1971 or earlier. As well, staff and residents of licensed seniors supportive-living facilities who were left out of the first phase will be eligible.

More than 437,000 Albertans qualify for the Pfizer and Moderna vaccines under Phase 2A.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“I’m so grateful for everyone who is signing up. I know many others are eager for their turn, and we were asking everyone to please be patient,” said Dr. Deena Hinshaw, Alberta’s chief medical officer of health, during Monday’s press conference.

Once Phase 2A is complete, the province will shift to Phase 2B — likely in April — which would open eligibility for adults with severe underlying conditions. Hinshaw said they have carefully considered the list of qualifying conditions and released the full list on Monday, which is available at alberta.ca/covid19-vaccine.

The list includes chronic heart disease, vascular disease, asplenia or dysfunction of the spleen, diabetes, immunosuppression, pregnancy, severe mental illness, substance use disorders, learning disabilities, and organ, bone marrow or stem cell transplant recipients. Chronic kidney, liver, neurological and respiratory diseases also made the list.

Each of these conditions has specific stipulations that are listed online. For example, mild or well-controlled asthma isn’t considered a severe underlying condition of respiratory disease.

However, people with underlying conditions will not need a note from a doctor or pharmacist when they book or attend their appointment.

“We will be operating on the honour system, which is the same approach being taken by Ontario and other provinces,” said Hinshaw.

She encourages people to consult with their doctor or pharmacist if they have any questions about whether or not they qualify.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Phase 2C is expected to launch in late April, Hinshaw said, as she provided updated information about those who will be eligible in this stage.

Included in this phase are residents and support staff at specific congregate living and work settings that are at risk for outbreaks, including correctional facilities, homeless shelters, meat-packing plants and group homes. This would include front-line police, transport and court sheriffs who work closely with eligible congregate populations.

Health-care workers such as pharmacists, dentists and other regulated health-care professionals, including students undertaking placement practicums in clinical areas and health-care workers on First Nation reserves, will also become eligible. And the vaccine will also be offered to caregivers of Albertans who are most at risk of severe outcomes such as designated family or support people of those in long-term care and up to two caregivers for children under 16 who have chronic conditions but can’t receive the vaccine themselves.

“Together, these phases represent a vast group of Albertans. More than 660,000 Albertans will be eligible under Phase 2B and another 400,000 will be able to book in Phase 2C,” said Hinshaw.

It will take some time to provide a vaccine to everyone who wants one in these stages, Hinshaw said.

“Vaccines save lives and their benefits far outweigh any risks. I continue encouraging everyone to book an appointment to be immunized,” she added.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“Until then, we must continue protecting each other. We must not let our guard down.”

Alberta detects 65 variant cases, 255 people in hospital

Alberta detected another 65 variant cases on Monday, all of them the B.1.1.7 strain that was first identified in the United Kingdom.

This brings the total of B.1.1.7 cases in the province to 967, while there have been 16 cases of the B.1.351 variant identified in South Africa and two of the P.1 strain discovered in Brazil.

Of the 985 variant cases reported to date, 474 remain active.

Alberta reported 364 new cases, which came from 6,618 tests for a positivity rate of about 5.5 per cent. There are 4,811 active cases provincewide.

The province’s R-value averaged 1.07 last week, meaning the transmission rate was increasing.

As of Monday, there were 255 people in hospital, including 42 in intensive-care units. This a slight increase from the 248 hospitalizations and 38 ICU admissions reported the day before.

Three COVID-19 deaths were reported Monday, including a woman in her 90s from the Calgary zone, a man in his 60s from the South zone and a man in his 80s from the Edmonton zone. The provincial death toll sits at 1,949.

Alberta has now administered 368,124 doses of COVID-19 vaccine, and 91,593 people have received both shots.

Alberta Health Services transitioned bookings for the AstraZeneca vaccine through its Health Link’s phone line only until supply is fully depleted. Bookings remain open for Albertans born between 1957 and 1961 and Indigenous individuals between 1972 and 1976.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Prime Minister Justin Trudeau offered reassurances on the safety of the Oxford-AstraZeneca COVID-19 vaccine on Monday as the list of European countries suspending its use due to safety concerns grew.

Germany joined others in Europe pausing their use of the AstraZeneca vaccine over reports of blood clots in some recipients, even though European regulators say there’s no evidence the shot is to blame.

Health Canada regulators are constantly analyzing all the available information about vaccines and have guaranteed those approved in Canada are safe for use, Trudeau told reporters in Montreal.

— With files from The Canadian Press

sbabych@postmedia.com
Twitter: @BabychStephanie

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending